Literature DB >> 11677265

Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons.

M I Nogueron1, B Porgilsson, W E Schneider, C L Stucky, C J Hillard.   

Abstract

Neuronal cannabinoid receptors (CB(1)) are coupled to inhibition of voltage-sensitive Ca(2+) channels (VSCCs) in several cell types. The purpose of these studies was to characterize the interaction between endogenous CB(1) receptors and VSCCs in cerebellar granule neurons (CGN). Ca(2+) transients were evoked by KCl-induced depolarization and imaged using fura-2. The CB(1) receptor agonists CP55940, Win 55212-2 and N-arachidonylethanolamine (anandamide) produced concentration-related decreases in peak amplitude of the Ca(2+) response and total Ca(2+) influx. Pre-treatment of CGN with pertussis toxin abolished agonist-mediated inhibition. The inhibitory effect of Win 55212-2 on Ca(2+) influx was additive with inhibition produced by omega-agatoxin IVA and nifedipine but not with omega-conotoxin GVIA, indicating that N-type VSCCs are the primary effector. Paradoxically, the CB(1) receptor antagonist, SR141716, also inhibited KCl-induced Ca(2+) influx into CGN in a concentration-related manner. SR141716 inhibition was pertussis toxin-insensitive and was not additive with the inhibition produced by Win 55212-2. Confocal imaging of CGN in primary culture demonstrate a high density of CB(1) receptor expression on CGN plasma membranes, including the neuritic processes. These data demonstrate that the CB(1) receptor is highly expressed by CGN and agonists serve as potent and efficacious inhibitory modulators of Ca(2+) influx through N-type VSCC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11677265     DOI: 10.1046/j.1471-4159.2001.00567.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Isolation of living neurons from human elderly brains using the immunomagnetic sorting DNA-linker system.

Authors:  Yoshihiro Konishi; Kristina Lindholm; Li-Bang Yang; Rena Li; Yong Shen
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 2.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 3.  Endocannabinoid system in neurodegenerative disorders.

Authors:  Balapal S Basavarajappa; Madhu Shivakumar; Vikram Joshi; Shivakumar Subbanna
Journal:  J Neurochem       Date:  2017-07-05       Impact factor: 5.372

4.  Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells.

Authors:  Rashmi Sood; Shawn Kalloway; Alan E Mast; Cecilia J Hillard; Hartmut Weiler
Journal:  Blood       Date:  2005-12-27       Impact factor: 22.113

Review 5.  Role of cannabinoids and endocannabinoids in cerebral ischemia.

Authors:  Cecilia J Hillard
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

6.  CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes.

Authors:  Paola Nieri; Rosamiria Greco; Barbara Adinolfi; Maria Cristina Breschi; Enrica Martinotti; Carla Nannetti; Adriano Podestà
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

7.  Multiple actions of anandamide on neonatal rat cultured sensory neurones.

Authors:  Rhian M Evans; Roderick H Scott; Ruth A Ross
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

8.  Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.

Authors:  Balapal S Basavarajappa
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

9.  Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum.

Authors:  H Daniel; A Rancillac; F Crepel
Journal:  J Physiol       Date:  2004-03-19       Impact factor: 5.182

10.  Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation.

Authors:  Haibin Wang; Hiromichi Matsumoto; Yong Guo; Bibhash C Paria; Richard L Roberts; Sudhansu K Dey
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.